evogene.com - חוב לטווח ארוך של החברה EVGN

Evogene Ltd. (EVGN) is implementing neural networks for plant breeding and drug synthesis. The daily price action reflects a value of 0.00. The business model relies on leasing software to industry behemoths, which minimizes costs and maximizes cash flow. Meanwhile, unique multi-omics developments create a significant defensive barrier, shielding the company from price wars with tech giants.

This indicator measures total liabilities with a maturity of more than one year, allowing for an assessment of long-term financial stability and the risk of credit pressure on capital. By analyzing the time series of the firm's long-term borrowings, an investor determines the margin of safety for Evogene Ltd. (EVGN) amid technological nationalism and software export restrictions that could complicate debt service.